Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Single-center study, single blind, comparative with the objective of evaluating the efficacy
and safety of an investigational product as an adjunct in the treatment of onychomycosis
improvement of 90 days ± 2 days.
Phase:
Phase 3
Details
Lead Sponsor:
MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA
Collaborator:
Buranello e Rodrigues Consultoria em Desenvolvimento Farmacêutico Ltda ME